{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:33:57Z","timestamp":1789832037777,"version":"4.0.1"},"reference-count":89,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,1,28]],"date-time":"2018-01-28T00:00:00Z","timestamp":1517097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Immunoglobulin 4 (IgG4) is one of four human IgG subclasses and has several unique functional characteristics. It exhibits low affinity for complement and for most Fc receptors. It furthermore has generally high affinity for its antigen, with binding occurring in a monovalent fashion, as IgG4 can exchange Fab\u2010arms with other IgG4 molecules. Because of these characteristics, IgG4 is believed to block its targets and prevent inflammation, which, depending on the setting, can have a protective or pathogenic effect. One example of IgG4 pathogenicity is muscle\u2010specific kinase (MuSK) myasthenia gravis (MG), in which patients develop IgG4 MuSK autoantibodies, resulting in muscle weakness. As a consequence of the distinct IgG4 characteristics, the pathomechanism of MuSK MG is very different from IgG1\u2010and IgG3\u2010mediated autoimmune diseases, such as acetylcholine receptor MG. In recent years, new autoantibodies in a spectrum of autoimmune diseases have been discovered. Interestingly, some were found to be predominantly IgG4. These IgG4\u2010mediated autoimmune diseases share many pathomechanistic aspects with MuSK MG, suggesting that IgG4\u2010mediated autoimmunity forms a separate niche among the antibody\u2010mediated disorders. In this review, we summarize the group of IgG4\u2010mediated autoimmune diseases, discuss the role of IgG4 in MuSK MG, and highlight interesting future research questions for IgG4\u2010mediated autoimmunity.<\/jats:p>","DOI":"10.1111\/nyas.13561","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T20:03:00Z","timestamp":1517256180000},"page":"92-103","source":"Crossref","is-referenced-by-count":73,"title":["IgG4\u2010mediated autoimmune diseases: a niche of antibody\u2010mediated disorders"],"prefix":"10.1111","volume":"1413","author":[{"given":"Maartje G.","family":"Huijbers","sequence":"first","affiliation":[{"name":"Departments of Neurology Leiden University Medical Centre  Leiden the Netherlands"},{"name":"Department of Human Genetics Leiden University Medical Centre  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap J.","family":"Plomp","sequence":"additional","affiliation":[{"name":"Departments of Neurology Leiden University Medical Centre  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silv\u00e8re M.","family":"van der Maarel","sequence":"additional","affiliation":[{"name":"Department of Human Genetics Leiden University Medical Centre  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Verschuuren","sequence":"additional","affiliation":[{"name":"Departments of Neurology Leiden University Medical Centre  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,1,28]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1584322"},{"key":"e_1_2_8_3_1","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti\u2010inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"der Neut K.M.","year":"2007","journal-title":"Science"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003336"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.541813"},{"key":"e_1_2_8_6_1","first-page":"415","article-title":"Inhibition of complement activation by IgG4 antibodies","volume":"64","author":"der Zee J.S.","year":"1986","journal-title":"Clin. Exp. Immunol"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-179754"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0804338"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198906013202206"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12758"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00010.2016"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx124"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.03.010"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003796"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202204"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2009.04.004"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22279"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03568.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.07.044"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2013.11.014"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000077"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.178"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182407982"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30070-3"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.528489"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.53.372"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000150587.71497.B6"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90244-F"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21371"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2006.03.016"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws025"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.10.031"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000307751.20968.f1"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2011.04.018"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI21545"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2012.01.025"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2015.12.016"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20061"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.01.013"},{"key":"e_1_2_8_40_1","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94263","article-title":"Autoantibody\u2010producing plasmablasts after B cell depletion identified in muscle\u2010specific kinase myasthenia gravis","volume":"2","author":"Stathopoulos P.","year":"2017","journal-title":"JCI Insight"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1313944110"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080695"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.11.005"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4130-07.2008"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2010.190298"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318237f660"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.00708.x"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12017.x"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2006.03.006"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1747.2003.12608.x"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.11.5239"},{"key":"e_1_2_8_52_1","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1172\/JCI64413","article-title":"Pemphigus autoantibodies generated through somatic mutations target the desmoglein\u20103 cis\u2010interface","volume":"122","author":"Di Z.G.","year":"2012","journal-title":"J. Clin. Invest."},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-007-0734-0"},{"key":"e_1_2_8_54_1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jnci\/58.2.189","article-title":"IgG4 subclass in malignant melanoma","volume":"58","author":"Daveau M.","year":"1977","journal-title":"J. Natl. Cancer Inst"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI65579"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0110-z"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9705-0"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60720-0"},{"key":"e_1_2_8_59_1","article-title":"IgG4\u2010related disease: a complex under\u2010diagnosed clinical entity","author":"Yadlapati S.","year":"2017","journal-title":"Rheumatol. Int."},{"key":"e_1_2_8_60_1","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.4049\/jimmunol.150.9.3941","article-title":"Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis","volume":"150","author":"Kurniawan A.","year":"1993","journal-title":"J. Immunol"},{"key":"e_1_2_8_61_1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4049\/jimmunol.130.2.722","article-title":"Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4\u2010restricted response","volume":"130","author":"Aalberse R.C.","year":"1983","journal-title":"J. Immunol"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.3.747"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.8.3730"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2005.01.001"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2250"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1985.tb00253.x"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.8.4718"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.2.727"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123546"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2014.992517"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.10.1358"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20121486"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000444"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017020178"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1512561112"},{"key":"e_1_2_8_76_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00281-015-0541-1","article-title":"Immune response in pemphigus and beyond: progresses and emerging concepts","volume":"38","author":"Di Z.G.","year":"2016","journal-title":"Semin. Immunopathol"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww189"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003887"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.11.006"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)30018-7"},{"key":"e_1_2_8_81_1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4049\/jimmunol.153.3.1333","article-title":"Human monoclonal autoantibodies specific for the bullous pemphigoid antigen 1 (BPAg 1)","volume":"153","author":"Peyron E.","year":"1994","journal-title":"J. Immunol."},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.8206.1"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23794"},{"key":"e_1_2_8_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000233"},{"key":"e_1_2_8_85_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-561142"},{"key":"e_1_2_8_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12729"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00893.x"},{"key":"e_1_2_8_88_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85265"},{"key":"e_1_2_8_89_1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.berh.2016.02.006","article-title":"HLA and anti\u2010citrullinated protein antibodies: building blocks in RA","volume":"29","author":"der Woude D.","year":"2015","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"e_1_2_8_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.43"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnyas.13561","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nyas.13561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T14:45:41Z","timestamp":1694616341000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/nyas.13561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,28]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1111\/nyas.13561"],"URL":"https:\/\/doi.org\/10.1111\/nyas.13561","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,28]]}}}